ClinicalTrials.Veeva

Menu

Use of Virtual Reality in Pain Management in Pediatric Oncology (DOREVI)

C

Centre Hospitalier Universitaire de la Réunion

Status

Enrolling

Conditions

Pediatric Tumor

Treatments

Other: Virtual reality headset

Study type

Interventional

Funder types

Other

Identifiers

NCT05592132
2022/CHU/11

Details and patient eligibility

About

DOREVI is a monocentric randomized controlled study that will evaluate the efficacy of virtual reality helmets for pain prevention during invasive care on 78 oncologic pediatric patients. Two groups of children (between 6 and 11 and between 12 and 18 years old) will be randomized to use helmet plus standard care or standard care alone during invasive procedures (central venous catheter puncture, lumbar puncture, or bone marrow aspiration). The pain intensity will be evaluated using a visual analogic scale during three invasive procedures, and results will be compared between the patients with or without virtual reality.

Enrollment

74 estimated patients

Sex

All

Ages

6 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patient who tolerates the virtual reality headset
  • patient followed in pediatric oncology
  • patient with a diagnosis of benign tumor or cancer
  • patient who needs to have painful medical procedure during their treatment
  • patient whose parents have signed the informed consent
  • patient affiliated with social security or equivalent

Exclusion criteria

  • patient with visual or hearing impairement
  • patient with epilepsy or other neurological disease
  • patient with psychiatric disease

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

74 participants in 2 patient groups

Intervention
Experimental group
Description:
Patients randomized in this arm will have the virtual reality headset associated to the standard care
Treatment:
Other: Virtual reality headset
Standard care
No Intervention group
Description:
patients randomized in this arm will have standard care.

Trial contacts and locations

1

Loading...

Central trial contact

Emilie TECHER; Yves REGUERRE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems